A Patient with Hyperlipidemia who Had a Gallbladder Stone Caused by Administration of Fenofibrate

Fibrates are widely used for treatment of hyperlipidemia. It has been reported that gallbladder stones are formed by administration of clofibrate. It is thought that fenofibrate can cause the formation of gallbladder stone as a side effect. We encountered a patient with hyperlipidemia in whom a gall...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kurume medical journal 2003/06/13, Vol.50(1-2), pp.77-80
Hauptverfasser:	INUZUKA, SADATAKA, TOMIYASU, NOBUO, KUMAMOTO, MASAFUMI, EGASHIRA, TATUNARI, KINOSHITA, JUNNJI, SHISHIDO, SYOICHIRO, SATA, MICHIO, UENO, TAKATO
Format:	Artikel
Sprache:	eng
Schlagworte:	Cholelithiasis - chemically induced Cholelithiasis - complications Cholelithiasis - diagnostic imaging Female fenofibrate Fenofibrate - adverse effects gallbladder stone Humans hyperlipidemia Hyperlipidemias - complications Hypolipidemic Agents - adverse effects Middle Aged peroxisome proliferator-activated receptor α (PPARα) Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Fibrates are widely used for treatment of hyperlipidemia. It has been reported that gallbladder stones are formed by administration of clofibrate. It is thought that fenofibrate can cause the formation of gallbladder stone as a side effect. We encountered a patient with hyperlipidemia in whom a gallbladder stone was detected by computed tomographic scanning 3 months after the start of administration of fenofibrate during follow-up observation by blood biochemical examination and computed tomographic scanning. This case report will be of great value and importance.
ISSN:	0023-5679 1881-2090
DOI:	10.2739/kurumemedj.50.77